Baumgartner M R, Verhoeven N M, Jakobs C, Roels F, Espeel M, Martinez M, Rabier D, Wanders R J, Saudubray J M
Department of Pediatrics, Hôpital Necker-Enfants Malades, Paris, France.
Neurology. 1998 Nov;51(5):1427-32. doi: 10.1212/wnl.51.5.1427.
Characterization of the defect in a patient presenting a peripheral neuropathy with atypical features of distal motor involvement mimicking Werdnig-Hoffmann disease.
Clinical signs included generalized hypotonia and floppiness, absence of stretch reflexes, muscle wasting, lack of head control and lingual fasciculations associated with unaffected facial muscles, and normal intellectual development.
Normal muscle histology ruled out Werdnig-Hoffmann disease. Elevated plasma concentrations of very long-chain fatty acids and bile acid intermediates combined with normal plasmalogen levels in erythrocytes suggested defective peroxisomal beta-oxidation directly demonstrated by deficient pristanic acid and partially deficient C26:0 was present oxidation in cultured fibroblasts. Severely impaired pipecolic acid oxidation in liver and phytanic acid oxidation in fibroblasts was present. On light and electron microscopy of the liver tissue, rare peroxisomal membrane ghosts and trilamellar inclusions but absence of peroxisomes was noted. Immunoblot analysis revealed absence of peroxisomal beta-oxidation enzymes in liver tissue but normal results in fibroblasts. Remarkably, expression of the peroxisomal defect in fibroblasts was indicated by the finding of mainly cytoplasmatic catalase, as in liver. Preliminary studies excluded classification of this patient within the large PEX1 complementation group.
The results suggest a novel peroxisome biogenesis disorder involving peroxisomal beta-oxidation as well as phytanic and pipecolic acid oxidation rather than an isolated defect of peroxisomal beta-oxidation. The association of a clinical picture mimicking Werdnig-Hoffmann disease with a novel peroxisomal disorder raises the question of whether investigation for peroxisomal function should be considered in every patient with an enigmatic spinal muscular atrophy-like syndrome.
对一名表现为周围神经病的患者的缺陷进行特征描述,该患者具有模仿韦尔尼克 - 霍夫曼病的远端运动受累的非典型特征。
临床体征包括全身肌张力减退和松软、无牵张反射、肌肉萎缩、缺乏头部控制以及与面部肌肉未受累相关的舌肌束颤,且智力发育正常。
正常的肌肉组织学排除了韦尔尼克 - 霍夫曼病。血浆中极长链脂肪酸和胆汁酸中间体浓度升高,同时红细胞中缩醛磷脂水平正常,提示过氧化物酶体β氧化存在缺陷,培养的成纤维细胞中降植烷酸缺乏和C26:0氧化部分缺乏直接证明了这一点。肝脏中哌啶酸氧化严重受损,成纤维细胞中植烷酸氧化也存在问题。在肝脏组织的光镜和电镜检查中,发现罕见的过氧化物酶体膜空壳和三层包涵体,但未发现过氧化物酶体。免疫印迹分析显示肝脏组织中缺乏过氧化物酶体β氧化酶,但成纤维细胞结果正常。值得注意的是,如在肝脏中一样,主要在细胞质中发现过氧化氢酶,这表明成纤维细胞中存在过氧化物酶体缺陷。初步研究排除了该患者属于大型PEX1互补组的分类。
结果提示一种新的过氧化物酶体生物发生障碍,涉及过氧化物酶体β氧化以及植烷酸和哌啶酸氧化,而非单纯的过氧化物酶体β氧化缺陷。模仿韦尔尼克 - 霍夫曼病的临床表现与一种新的过氧化物酶体疾病的关联,引发了对于每一位患有不明原因的脊髓性肌萎缩样综合征的患者是否都应考虑进行过氧化物酶体功能检查这一问题。